1,2-distearoyllecithin has been researched along with chitosan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, A; Makhlof, A; Ping, Q; Takeuchi, H; Tozuka, Y | 1 |
| Ha, DH; Han, HK; Shin, HJ | 1 |
| Barison, A; Camarozano, AC; de Freitas, RA; Dos Santos, LA; Kaminski, GA; Ocampos, FM; Picheth, GF; Pirich, CL; Pontarolo, R; Sierakowski, MR | 1 |
3 other study(ies) available for 1,2-distearoyllecithin and chitosan
| Article | Year |
|---|---|
N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
Topics: Administration, Oral; Animals; Blood; Bone Density Conservation Agents; Calcitonin; Calcium; Chitosan; Cholesterol; Coumarins; Drug Carriers; Hydrogen-Ion Concentration; Intestine, Small; Magnetic Resonance Spectroscopy; Male; Microscopy, Atomic Force; Mucins; Organophosphates; Particle Size; Phosphatidylcholines; Rats; Rats, Wistar; Static Electricity; Surface Properties; Thiazoles; Unilamellar Liposomes | 2011 |
Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
Topics: Adhesiveness; Administration, Oral; Alendronate; Animals; Biological Availability; Bone Density Conservation Agents; Caco-2 Cells; Chemistry, Pharmaceutical; Chitosan; Drug Stability; Humans; Intestinal Absorption; Intestinal Mucosa; Lipids; Liposomes; Male; Mucins; Nanoparticles; Particle Size; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Technology, Pharmaceutical | 2012 |
Chitosan-coated microvesicles: Effect of polysaccharide-phospholipid affinity on decafluorobutane dissolution.
Topics: Chitosan; Contrast Media; Fluorocarbons; Microbubbles; Phosphatidylcholines; Phospholipids; Solubility; Ultrasonography | 2016 |